{"id":15066,"date":"2026-11-04T10:26:54","date_gmt":"2026-11-04T09:26:54","guid":{"rendered":"https:\/\/bict.it\/?p=15066"},"modified":"2026-11-04T10:27:13","modified_gmt":"2026-11-04T09:27:13","slug":"when-a-transaminase-beats-a-reductive-amination","status":"publish","type":"post","link":"https:\/\/bict.it\/en\/when-a-transaminase-beats-a-reductive-amination\/","title":{"rendered":"When a transaminase beats a reductive amination"},"content":{"rendered":"

There is more than one way to a chiral amine, and the choice is not made on the reaction: it is made on the point where the process jams. In a reduction, the critical point is the carbonyl face the hydride arrives at. In a transamination, the critical point is the equilibrium. Moving the question from the enzyme to the equilibrium is already half the development work.<\/p>\n

The short answer<\/h2>\n

A transaminase is worth it when the amine has to be enantiopure and the alternatives pay for that purity with a metal, with a pressure, or with half the yield.<\/p>\n

Chemical reductive amination<\/strong> reaches the amine in a single step, and it is robust; but on a prochiral ketone it returns the racemate. The enantiomer you need is recovered by a resolution, and half the material leaves through the wrong door, with its synthesis cost already paid.<\/p>\n

Asymmetric hydrogenation<\/strong> solves the selectivity, and pays for it elsewhere: a transition-metal catalyst, usually rhodium or ruthenium, with its chiral ligand; pressure equipment; and a metal residue to keep under control in the final product, where the reference is ICH Q3D and scavenging is never free.<\/p>\n

A transaminase<\/strong> does the same job in water, at ambient pressure, with a single enantiomer coming out and no metals. There is a price here too, and it sits somewhere other than where people usually look for it.<\/p>\n

The constraint that decides is the equilibrium<\/h2>\n

An ω-transaminase does not reduce: it transfers. It takes the amino group from a donor, parks it on pyridoxal phosphate as pyridoxamine phosphate, and passes it from there to the ketone. The mechanism is ping-pong, with the enzyme changing state between the two half reactions, and above all it is reversible in both.<\/p>\n

So the technical question is not “is there an enzyme that accepts my ketone”, but where the equilibrium sits and what it costs to move it<\/strong>. On many ketones, and particularly on those with bulk near the carbonyl, the equilibrium sits on the reagent side: thermodynamic conversion stops at values that do not hold up economically, however good the enzyme is. A faster enzyme simply reaches the same wall sooner.<\/p>\n

There are three tools for moving it, and on scale they are used together.<\/p>\n